TY  - JOUR

T1  - Modeling the selective growth advantage of genetically variant human pluripotent stem cells to identify opportunities for manufacturing process control

JO  - Cytotherapy

UR  - http://dx.doi.org/10.1016/j.jcyt.2024.01.010

PY  - 2024/01/01

AU  - Beltran-Rendon C

AU  - Price CJ

AU  - Glen K

AU  - Stacey A

AU  - Barbaric I

AU  - Thomas RJ

ED  - 

DO  - DOI: 10.1016/j.jcyt.2024.01.010

PB  - Elsevier BV

Y2  - 2024/12/22

ER  -